Therapy News and Research

RSS

Study shows adequate sleep may accelerate antidepressant treatment response

Medication is an important part of treatment for many patients with major depressive disorder, but the transition to antidepressants isn't always smooth.

7 Sep 2016

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

7 Sep 2016

New computer program can predict underlying genomics of ER+ breast cancer

The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy, researchers at Case Western Reserve University have found.

7 Sep 2016

Groundbreaking research on effects of NIR light could lead to effective treatment for PTSD

After years of studying the effects of near-infrared light on veterans with post-traumatic stress disorder or traumatic brain injuries, a team led by a University of Texas at Arlington bioengineer has published groundbreaking research in Nature's Scientific Reports that could result in an effective, long-term treatment for brain disorders.

7 Sep 2016

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk.

7 Sep 2016

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say.

7 Sep 2016

Researchers isolate cord blood factor that helps fight harmful inflammation

A factor found in umbilical cord blood could become the basis for developing a new therapy to fight harmful inflammation, University of Utah School of Medicine researchers report.

7 Sep 2016

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Researchers from Massachusetts Eye and Ear/Harvard Medical School have found that patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone.

7 Sep 2016

PSA failure linked to increased risk of death among healthy men

A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.

6 Sep 2016

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University, the Atlanta Veterans Affairs Medical Center and Wenzhou Medical University and Southwest University in China.

6 Sep 2016

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Two studies appearing in the September 6 issue of JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia (HHT), an inherited condition characterized by abnormal blood vessels which are delicate and prone to bleeding.

6 Sep 2016

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips Respironics, a division of Royal Philips, will showcase its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) International Congress 2016 in London (September 3-7).

6 Sep 2016

New software that simulates interventions could spare young heart patients from surgery

Children with congenital heart defects often undergo a battery of strenuous examinations and interventions. In the EU CARDIOPROOF project, Fraunhofer researchers have developed software to simulate certain interventions in advance.

6 Sep 2016

New Focused Update to CCS atrial fibrillation guidelines released

The Canadian Journal of Cardiology has just released the 2016 Focused Update to the Canadian Cardiovascular Society's atrial fibrillation (AF) guidelines.

6 Sep 2016

Enzyme from oral bacteria could be potential therapy for celiac disease

Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease (CD), an autoimmune disorder that causes severe digestive and other health problems among sufferers when they consume gluten.

6 Sep 2016

NUS study could contribute to reducing acquired resistance to combination drug treatment in cancer

A team of scientists led by Dr Bhaskar Bhattacharya and Associate Professor Richie Soong from the Cancer Science Institute of Singapore at the National University of Singapore conducted a study on acquired resistance (AQR) to combination drug treatment in cancer and found that the mechanisms of AQR for the combination drugs were different from that of the individual drugs.

6 Sep 2016

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.

6 Sep 2016

HIF-2 inhibitors could be promising target to combat kidney cancer

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

6 Sep 2016

Novel technique offers new insights into growth variation across single cells

A new technique invented at MIT can precisely measure the growth of many individual cells simultaneously.

5 Sep 2016

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union and, though to a smaller degree, in Japan by 2020, according to new research published in the leading cancer journal Annals of Oncology today (Tuesday).

5 Sep 2016

Therapy News and Research

Study shows adequate sleep may accelerate antidepressant treatment response

Researchers unlock genetic code that disrupts response to breast cancer therapy

New computer program can predict underlying genomics of ER+ breast cancer

Groundbreaking research on effects of NIR light could lead to effective treatment for PTSD

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Researchers isolate cord blood factor that helps fight harmful inflammation

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

PSA failure linked to increased risk of death among healthy men

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

New software that simulates interventions could spare young heart patients from surgery

New Focused Update to CCS atrial fibrillation guidelines released

Enzyme from oral bacteria could be potential therapy for celiac disease

NUS study could contribute to reducing acquired resistance to combination drug treatment in cancer

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

HIF-2 inhibitors could be promising target to combat kidney cancer

Novel technique offers new insights into growth variation across single cells

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News